J, T., M, G., A, G., M, G., R, M., E, R., . . . M, A. (2022). Recommendations for the use of biomarkers for head and neck cancer, including salivary gland tumours: A consensus of the Spanish Society of Medical Oncology and the Spanish Society of Pathology. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 24(10), 1890. https://doi.org/10.1007/s12094-022-02856-1
Chicago Style (17th ed.) CitationJ, Trigo, et al. "Recommendations for the Use of Biomarkers for Head and Neck Cancer, Including Salivary Gland Tumours: A Consensus of the Spanish Society of Medical Oncology and the Spanish Society of Pathology." Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 24, no. 10 (2022): 1890. https://doi.org/10.1007/s12094-022-02856-1.
MLA (9th ed.) CitationJ, Trigo, et al. "Recommendations for the Use of Biomarkers for Head and Neck Cancer, Including Salivary Gland Tumours: A Consensus of the Spanish Society of Medical Oncology and the Spanish Society of Pathology." Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, vol. 24, no. 10, 2022, p. 1890, https://doi.org/10.1007/s12094-022-02856-1.
